Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Market Study on Cancer Supportive Care Products: Lung Cancer to Become Second Largest Disease Indication by 2021

Table of Content

1. Executive Summary

2. Research Methodology

3. Assumption & Acronyms Used

4. Market Overview
4.1. Parent Market Overview
4.2. Market Taxonomy & Market Definition
4.3. Global Cancer Supportive Care Products Market Size and Forecast
     4.3.1. Introduction
     4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021)
4.4. Global Cancer Supportive Care Products Market Dynamics
     4.4.1. Drivers
     4.4.2. Restraints
     4.4.3. Trends
     4.4.4. Opportunity

5. Regulations & PEST Analysis

6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class
     6.1.1. Introduction
     6.1.2. Y-o-Y Growth Comparison, By Drug Class
     6.1.3. BPS Analysis, By Drug Class
            6.1.3.1. Nonsteroidal Anti-inflammatory Drugs
            6.1.3.2. Anti-infective
            6.1.3.3. Anti-emetics
            6.1.3.4. Monoclonal Antibodies
            6.1.3.5. Erythropoietin Stimulating Agents 
            6.1.3.6. Opioid Analgesics
            6.1.3.7. Bisphosphonates
            6.1.3.8. Granulocyte Colony Stimulating Factor
     6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class

7. Global Cancer Supportive Care Products Market Analysis and Forecast By Indication
7.1. Introduction
     7.1.1. Y-o-Y Growth Comparison, By Indication
     7.1.2. BPS Analysis, By Indication
            7.1.2.1. Lung Cancer
            7.1.2.2. Breast Cancer
            7.1.2.3. Prostate Cancer
            7.1.2.4. Liver Cancer
            7.1.2.5. Bladder Cancer
            7.1.2.6. Leukaemia
            7.1.2.7. Ovarian Cancer
            7.1.2.8. Melanoma
            7.1.2.9. Other Cancer
     7.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication

8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution Channel
8.1. Introduction
     8.1.1. Y-o-Y Growth Comparison, By Distribution Channel
     8.1.2. BPS Analysis, By Distribution Channel
            8.1.2.1. Hospital Pharmacies
            8.1.2.2. Retail Pharmacies
            8.1.2.3. Compounding Pharmacies
     8.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel

9. Global Cancer Supportive Care Products Market Analysis and Forecast By Region
9.1. Introduction
     9.1.1. Y-o-Y Growth Comparison, By Region
     9.1.2. BPS Analysis, By Region
            9.1.2.1. North America
            9.1.2.2. Latin America
            9.1.2.3. Europe
            9.1.2.4. Asia Pacific
            9.1.2.5. MEA
     9.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Region

10. North America Cancer Supportive Care Products Market Analysis
10.1. Introduction
10.2. U.S.
     10.2.1. Market Value & Y-o-Y Growth
     10.2.2. Absolute $ Opportunity
10.3. Canada
     10.3.1. Market Value & Y-o-Y Growth
     10.3.2. Absolute $ Opportunity
10.4. North America Cancer Supportive Care Products Market Value By Drug Class
10.5. North America Cancer Supportive Care Products Market Value By Disease Indication
10.6. North America Cancer Supportive Care Products Market Value By Distribution Channel
10.7. North America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
10.8. North America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
10.9. North America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
10.10. North America Cancer Supportive Care Products Market Attractiveness Analysis By Country

11. Latin America Cancer Supportive Care Products Market Analysis
11.1. Introduction
11.2. Argentina
     11.2.1. Market Value & Y-o-Y Growth
     11.2.2. Absolute $ Opportunity
11.3. Brazil
     11.3.1. Market Value & Y-o-Y Growth
     11.3.2. Absolute $ Opportunity
11.4. Mexico
     11.4.1. Market Value & Y-o-Y Growth
     11.4.2. Absolute $ Opportunity
11.5. Rest of Latin America
     11.5.1. Market Value & Y-o-Y Growth
     11.5.2. Absolute $ Opportunity
11.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
11.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
11.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
11.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
11.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
11.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
11.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country

12. Latin America Cancer Supportive Care Products Market Analysis
12.1. Introduction
12.2. Argentina
     12.2.1. Market Value & Y-o-Y Growth
     12.2.2. Absolute $ Opportunity
12.3. Brazil
     12.3.1. Market Value & Y-o-Y Growth
     12.3.2. Absolute $ Opportunity
12.4. Mexico
     12.4.1. Market Value & Y-o-Y Growth
     12.4.2. Absolute $ Opportunity
12.5. Rest of Latin America
     12.5.1. Market Value & Y-o-Y Growth
     12.5.2. Absolute $ Opportunity
12.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
12.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
12.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
12.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
12.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
12.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
12.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country

13. Europe Cancer Supportive Care Products Market Analysis
13.1. Introduction
13.2. Germany
     13.2.1. Market Value & Y-o-Y Growth
     13.2.2. Absolute $ Opportunity
13.3. U.K.
     13.3.1. Market Value & Y-o-Y Growth
     13.3.2. Absolute $ Opportunity
13.4. France
     13.4.1. Market Value & Y-o-Y Growth
     13.4.2. Absolute $ Opportunity
13.5. Italy
     13.5.1. Market Value & Y-o-Y Growth
     13.5.2. Absolute $ Opportunity
13.6. Spain
     13.6.1. Market Value & Y-o-Y Growth
     13.6.2. Absolute $ Opportunity
13.7. Nordic
     13.7.1. Market Value & Y-o-Y Growth
     13.7.2. Absolute $ Opportunity
13.8. Russia
     13.8.1. Market Value & Y-o-Y Growth
     13.8.2. Absolute $ Opportunity
13.9. Rest of Europe
     13.9.1. Market Value & Y-o-Y Growth
     13.9.2. Absolute $ Opportunity
     13.9.3. 
13.10. Europe Cancer Supportive Care Products Market Value By Drug Class
13.11. Europe Cancer Supportive Care Products Market Value By Disease Indication
13.12. Europe Cancer Supportive Care Products Market Value By Distribution Channel
13.13. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
13.14. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication
13.15. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
13.16. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country

14. Asia Pacific Cancer Supportive Care Products Market Analysis
14.1. Introduction
14.2. Greater China
     14.2.1. Market Value & Y-o-Y Growth
     14.2.2. Absolute $ Opportunity
14.3. India
     14.3.1. Market Value & Y-o-Y Growth
     14.3.2. Absolute $ Opportunity
14.4. Japan
     14.4.1. Market Value & Y-o-Y Growth
     14.4.2. Absolute $ Opportunity
14.5. Australia and New Zealand
     14.5.1. Market Value & Y-o-Y Growth
     14.5.2. Absolute $ Opportunity
14.6. Rest of APAC
     14.6.1. Market Value & Y-o-Y Growth
     14.6.2. Absolute $ Opportunity
14.7. Asia Pacific Cancer Supportive Care Products Market Value By Drug Class
14.8. Asia Pacific Cancer Supportive Care Products Market Value By Disease Indication
14.9. Asia Pacific Cancer Supportive Care Products Market Value By Distribution Channel
14.10. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
14.11. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Indication
14.12. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
14.13. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Country

15. MEA Cancer Supportive Care Products Market Analysis
15.1. Introduction
15.2. GCC
     15.2.1. Market Value & Y-o-Y Growth
     15.2.2. Absolute $ Opportunity
15.3. South Africa
     15.3.1. Market Value & Y-o-Y Growth
     15.3.2. Absolute $ Opportunity
15.4. Rest of MEA
     15.4.1. Market Value & Y-o-Y Growth
     15.4.2. Absolute $ Opportunity
15.5. MEA Cancer Supportive Care Products Market Value By Drug Class
15.6. MEA Cancer Supportive Care Products Market Value By Disease Indication
15.7. MEA Cancer Supportive Care Products Market Value By Distribution Channel
15.8. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
15.9. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication
15.10. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
15.11. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country

16. Competitive Landscape
16.1. Amgen Inc.
16.2. Johnson & Johnson Private Ltd.
16.3. Novartis AG
16.4. Baxter International Inc
16.5. Hoffmann-La Roche Ltd.
16.6. Fagron Group BV
16.7. Teva Pharmaceutical Industries Ltd.

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote